Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Antiplatelet Therapy With Clopidogrel Alone Versus Clopidogrel Plus Aspirin After Completion of 9- to 12-month Dual Antiplatelet Therapy for ACS Patients With Both High Bleeding and Ischemic Risk.

NCT03431142 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.

NCT NCT03431142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03431142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Antiplatelet Therapy With Clopidogrel Alone Versus Clopidogrel Plus Aspirin After Completion of 9- to 12-month Dual Antiplatelet Therapy for ACS Patients With Both High Bleeding and Ischemic Risk.
Lead sponsor
Shenyang Northern Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 12, 2018
Completion date
December 30, 2020
Enrollment
7,758 (actual)
Sites
103

Conditions

As the registry lists them; a condition with its own page is linked.

prolonged dapt in acs patients with hisk of both ischemic and hemorrhage